Bibliographic Details
| Title: |
A novel hyperactive BCR::ABL1 e6a3 variant confers resistance to combined asciminib plus ponatinib therapy. |
| Authors: |
Nardi V, Schwieterman J, Ansari S, Kincaid Z, Azhar M, Yousuf T, Amir N, Khan A, Kesarwani M, Ryall S, Brunner AM, Capilla Guerra MR, Griffin GK, Nassar N, Daley GQ, Azam M |
| Source: |
MedRxiv : the preprint server for health sciences [medRxiv] 2026 Apr 24. Date of Electronic Publication: 2026 Apr 24. |
| Publication Type: |
Journal Article; Preprint |
| Journal Info: |
Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE |
| Database: |
MEDLINE Ultimate |
